Fig. 4

Survival outcomes in patients with high (> 5.4) and low (≤ 5.4) ACR. a OS rate in the subgroup of tumor size < 5 cm. b DFS rate in the subgroup of tumor size < 5 cm. c OS rate in the subgroup of early stage (I or II). d DFS rate in the subgroup of early stage (I or II). e OS rate in the subgroup of AFP <  400 ng / mL. f DFS rate in the subgroup of AFP <  400 ng / mL. g OS rate in the subgroup of platelet / CRP <  47.8. h DFS rate in the subgroup of platelet / CRP <  47.8